SynVaccine Company

SynVaccine develops preventive viral vaccines for various major human pathogens.
Technology: Biologics (vaccine)
Industry: Geroscience
Headquarters: Tel Aviv, Tel Aviv, Israel
Founded Date: 2013-01-01
Employees Number: 1-10
Investors Number: 2
Total Funding: 1756064
Estimated Revenue: Less than $1M
Last Funding Date: 2018-09-23
Last Funding Type: Seed

Visit Website
info@SynVaccine.com
http://www.synvaccine.com/
Register and Claim Ownership